Final answer:
The appropriate management for the 64-year-old patient with microcytic anemia is to measure the reticulocyte count to determine the nature of anemia, whether it is due to decreased production or increased destruction of red blood cells.
Step-by-step explanation:
The patient is a 64-year-old male with a medical history of hypertension, osteoarthritis, and generalized anxiety disorder, who is on hydrochlorothiazide, ibuprofen, atenolol, and paroxetine. The laboratory results demonstrate a hemoglobin level of 10.1 g/dL and a mean corpuscular volume (MCV) of 73 fL, which indicates microcytic anemia. The most appropriate next step in the management of this patient is to measure the reticulocyte count (Option B). This test will help determine whether the anemia is due to decreased production or increased destruction of red blood cells. If the reticulocyte count is low, it indicates underproduction, which can be caused by iron deficiency or chronic disease. If it is high, it indicates a destruction or loss of red blood cells, suggesting possible hemolysis or hemorrhage. Given the patient's use of ibuprofen, a known cause of gastrointestinal bleeding, and the lack of obvious hemolysis signs or symptoms, measuring the reticulocyte count is a logical next step.